Archives of Plastic Surgery

Korean Society of Plastic and Reconstructive Surgeons (대한성형외과학회)
권호 표지
DOI QR코드

DOI QR Code

Comparative Study of Multimodal Therapy in Facial Palsy Patients

  • Received : 2021.12.28
  • Accepted : 2022.07.07
  • Published : 2022.09.15
Download PDF
⟨ Previous Next ⟩

Abstract

Introduction In chronic facial palsy, synkinetic muscle overactivity and shortening causes muscle stiffness resulting in reduced movement and functional activity. This article studies the role of multimodal therapy in improving outcomes. Methods Seventy-five facial palsy patients completed facial rehabilitation before being successfully discharged by the facial therapy team. The cohort was divided into four subgroups depending on the time of initial attendance post-onset. The requirement for facial therapy, chemodenervation, or surgery was assessed with East Grinstead Grade of Stiffness (EGGS). Outcomes were measured using the Facial Grading Scale (FGS), Facial Disability Index, House-Brackmann scores, and the Facial Clinimetric Evaluation scale. Results FGS composite scores significantly improved posttherapy (mean-standard deviation, 60.13 ± 23.24 vs. 79.9 ± 13.01; confidence interval, -24.51 to -14.66, p < 0.0001). Analysis of FGS subsets showed that synkinesis also reduced significantly (p < 0.0001). Increasingly, late clinical presentations were associated with patients requiring longer durations of chemodenervation treatment (p < 0.01), more chemodenervation episodes (p < 0.01), increased doses of botulinum toxin (p < 0.001), and having higher EGGS score (p < 0.001). Conclusions This study shows that multimodal facial rehabilitation in the management of facial palsy is effective, even in patients with chronically neglected synkinesis. In terms of the latency periods between facial palsy onset and treatment initiation, patients presenting later than 2 years were still responsive to multimodal treatment albeit to a lesser extent, which we postulate is due to increasing muscle contracture within their facial muscles.

Keywords

References

  1. Proske U, Morgan DL, Gregory JE. Thixotropy in skeletal muscle and in muscle spindles: a review. Prog Neurobiol 1993;41(06):705-721 https://doi.org/10.1016/0301-0082(93)90032-N
  2. Aramideh M, Koelman JHTM, Devriese PP, VanderWerf F, Speelman JD. Thixotropy: a novel explanation for the cause of lagophthalmos after peripheral facial nerve palsy. Br J Ophthalmol 2002;86(08):839 https://doi.org/10.1136/bjo.86.8.839
  3. Aramideh M, Koelman JHTM, Devriese PP, Speelman JD, Ongerboer de Visser BW. Thixotropy of levator palpebrae as the cause of lagophthalmos after peripheral facial nerve palsy. J Neurol Neurosurg Psychiatry 2002;72(05):665-667 https://doi.org/10.1136/jnnp.72.5.665
  4. Walker DT, Hallam MJ, Ni Mhurchadha S, McCabe P, Nduka C. The psychosocial impact of facial palsy: our experience in one hundred and twenty six patients. Clin Otolaryngol 2012;37(06):474-477 https://doi.org/10.1111/coa.12026
  5. Hotton M, Bogart K, Briegel W, et al. Recommendations for Supporting the Psychological Well-being of Children and Adults with Facial Palsy. Facial Palsy UK International Consensus Document; 2021
  6. Angelov DN, Ceynowa M, Guntinas-Lichius O, et al. Mechanical stimulation of paralyzed vibrissal muscles following facial nerve injury in adult rat promotes full recovery of whisking. Neurobiol Dis 2007;26(01):229-242 https://doi.org/10.1016/j.nbd.2006.12.016
  7. Malhotra R, Ziahosseini K, Poitelea C, Litwin A, Sagili S. Platinum segments: a new platinum chain for adjustable upper eyelid loading. Br J Ophthalmol 2015;99(12):1680-1685 https://doi.org/10.1136/bjophthalmol-2015-306869
  8. van Landingham SW, Diels J, Lucarelli MJ. Physical therapy for facial nerve palsy: applications for the physician. Curr Opin Ophthalmol 2018;29(05):469-475 https://doi.org/10.1097/ICU.0000000000000503
  9. Shokri T, Patel S, Ziai K, Harounian J, Lighthall JG. Facial synkinesis: a distressing sequela of facial palsy. Ear Nose Throat J 2021. Doi:10.1177/01455613211054627
  10. Azizzadeh B, Nduka C. Management of Post-Facial Paralysis Synkinesis. Elsevier; New York: 2021
  11. Azizzadeh B, Irvine LE, Diels J, et al. Modified selective neurectomy for the treatment of post-facial paralysis synkinesis. Plast Reconstr Surg 2019;143(05):1483-1496 https://doi.org/10.1097/PRS.0000000000005590
  12. Diels HJ. Facial paralysis: is there a role for a therapist? Facial Plast Surg 2000;16(04):361-364 https://doi.org/10.1055/s-2000-15546
  13. Peitersen E. Bell's palsy: the spontaneous course of 2,500 peripheral facial nerve palsies of different etiologies. Acta Otolaryngol Suppl 2002;(549):4-30
  14. Engstrom M, Berg T, Stjernquist-Desatnik A, et al. Prednisolone and valaciclovir in Bell's palsy: a randomised, double-blind, placebocontrolled, multicentre trial. Lancet Neurol 2008;7(11):993-1000 https://doi.org/10.1016/S1474-4422(08)70221-7
  15. Marsk E, Bylund N, Jonsson L, et al. Prediction of nonrecovery in Bell's palsy using Sunnybrook grading. Laryngoscope 2012;122(04):901-906 https://doi.org/10.1002/lary.23210
  16. Brach JS, VanSwearingen JM. Physical therapy for facial paralysis: a tailored treatment approach. Phys Ther 1999;79(04):397-404 https://doi.org/10.1093/ptj/79.4.397
  17. Cabrol C, Elarouti L, Montava AL, et al. Sunnybrook Facial Grading System: intra-rater and inter-rater variabilities. Otol Neurotol 2021;42(07):1089-1094 https://doi.org/10.1097/MAO.0000000000003140
  18. VanSwearingen JM, Brach JS. The Facial Disability Index: reliability and validity of a disability assessment instrument for disorders of the facial neuromuscular system. Phys Ther 1996;76(12): 1288-1298, discussion 1298-1300 https://doi.org/10.1093/ptj/76.12.1288
  19. Kahn JB, Gliklich RE, Boyev KP, Stewart MG, Metson RB, McKenna MJ. Validation of a patient-graded instrument for facial nerve paralysis: the FaCE scale. Laryngoscope 2001;111(03):387-398 https://doi.org/10.1097/00005537-200103000-00005
  20. Texeira LJ, Valbuza JH, Prado GF. Physical therapy for Bell's palsy (idiopathic facial paralysis). Cochrane Database Syst Rev 2011;12:CD0006283
  21. Arslan F, Gokgoz MC, Binar M, Aydemir E, Durmaz A. Anxiety, depression, and hopelessness in patients before and after treatment for peripheral facial paralysis. Ear Nose Throat J 2018;97(4-5):E1-E4
  22. Robinson MW, Baiungo J. Facial rehabilitation: evaluation and treatment strategies for the patient with facial palsy. Otolaryngol Clin North Am 2018;51(06):1151-1167 https://doi.org/10.1016/j.otc.2018.07.011
  23. Cooper L, Lui M, Nduka C. Botulinum toxin treatment for facial palsy: a systematic review. J Plast Reconstr Aesthet Surg 2017;70(06):833-841 https://doi.org/10.1016/j.bjps.2017.01.009
  24. Karp E, Waselchuk E, Landis C, Fahnhorst J, Lindgren B, LyfordPike S. Facial rehabilitation as noninvasive treatment for chronic facial nerve paralysis. Otol Neurotol 2019;40(02):241-245 https://doi.org/10.1097/MAO.0000000000002107